On July 30, Crocs fell 6.9% in regular trading, trading at $117.365/share, with turnover of $76.96 million. The decline was triggered by weak third-quarter guidance issued alongside second-quarter results that, while beating estimates, failed to sustain a stock that had already rallied approximately 56% year-to-date.

Crocs reported Q2 adjusted EPS of $4.55, above the analyst consensus of $4.34, while revenue of $1.179 billion also exceeded the $1.148 billion estimate. However, the company projected Q3 adjusted diluted EPS of $3.20 to $3.30, significantly below the $3.53 analyst expectation, with Q3 revenue growth expected to be roughly flat year-over-year. Full-year guidance was raised to $13.70-$14.00 EPS and 1%-2% revenue growth, and the board approved a $1.5 billion increase to its share buyback program.

Despite the upside surprises in Q2 and raised annual outlook, the market exhibited a classic sell-the-news reaction. Multiple investment banks including Piper Sandler, Baird, and BofA had previously upgraded the stock with targets as high as $160, suggesting bullish expectations were already heavily priced in ahead of results.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)